Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.25 USD | +0.72% | -2.61% | +3.34% |
Apr. 25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
Financials (USD)
Sales 2024 * | 538M | Sales 2025 * | 579M | Capitalization | 856M |
---|---|---|---|---|---|
Net income 2024 * | 40M | Net income 2025 * | 57M | EV / Sales 2024 * | 1.84 x |
Net Debt 2024 * | 132M | Net Debt 2025 * | 79M | EV / Sales 2025 * | 1.61 x |
P/E ratio 2024 * |
21.9
x | P/E ratio 2025 * |
15.3
x | Employees | 3,500 |
Yield 2024 * |
0.22% | Yield 2025 * |
0.22% | Free-Float | 98.96% |
Latest transcript on Core Laboratories Inc.
1 day | +0.72% | ||
1 week | -2.61% | ||
Current month | -2.61% | ||
1 month | +6.79% | ||
3 months | +14.49% | ||
6 months | +2.07% | ||
Current year | +3.34% |
Managers | Title | Age | Since |
---|---|---|---|
Lawrence Bruno
CEO | Chief Executive Officer | 64 | - |
Christopher Hill
DFI | Director of Finance/CFO | 54 | - |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Curtis Anastasio
BRD | Director/Board Member | 67 | 23-06-27 |
Director/Board Member | 71 | 19-12-31 | |
Director/Board Member | 74 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 18.25 | +0.72% | 522,173 |
24-06-06 | 18.12 | +1.40% | 752,153 |
24-06-05 | 17.87 | -0.17% | 386,008 |
24-06-04 | 17.9 | -0.06% | 532,960 |
24-06-03 | 17.91 | -4.43% | 471,560 |
Delayed Quote Nyse, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.34% | 856M | |
0.00% | 7.77B | |
-20.42% | 2.61B | |
-15.64% | 2.58B | |
-29.66% | 1.78B | |
-14.06% | 1.02B | |
-12.87% | 998M | |
-2.70% | 736M | |
-24.05% | 708M | |
+28.36% | 702M |
- Stock Market
- Equities
- CLB Stock